Newsroom

Sorted by: Latest

-

CVR Energy Reports Third Quarter 2026 Results

SUGAR LAND, Texas--(BUSINESS WIRE)--CVR Energy, Inc. (“CVR Energy” or the “Company”) (NYSE: CVI) today announced its third quarter 2026 results including a net income attributable to CVR Energy stockholders of $570 million, or $5.67 per diluted share, and an adjusted earnings per diluted share of $4.00, compared to net income attributable to CVR Energy stockholders of $374 million, or $3.72 per diluted share, and an adjusted earnings per diluted share of 40 cents for the third quarter of 2025....
-

Northisle Commences Environmental Assessment Process for the North Island Project

VANCOUVER, British Columbia--(BUSINESS WIRE)--Northisle Copper and Gold Inc. (TSX-V: NCX, OTCQX: NTCPF) (“Northisle” or the “Company”) is pleased to announce that the Initial Project Description (“IPD”) for its 100%-owned North Island Project has been accepted by the British Columbia Environmental Assessment Office (“EAO”) and Impact Assessment Agency of Canada (“IAAC”), which was submitted on October 21, 2026. The acceptance of the IPD formally commences the provincial Environmental Assessment...
-

CVR Partners Reports Third Quarter 2026 Results

SUGAR LAND, Texas--(BUSINESS WIRE)--CVR Partners, LP (“CVR Partners” or the “Partnership”) (NYSE: UAN), a manufacturer of ammonia and urea ammonium nitrate (“UAN”) solution fertilizer products, today announced a net loss of $11 million, or $1.02 per common unit, and EBITDA of $20 million on net sales of $146 million for the third quarter of 2026, compared to net income of $43 million, or $4.08 per common unit, and EBITDA of $71 million on net sales of $164 million for the third quarter of 2025....
-

Ropeg Secures ET Approvals Across Asia and the U.S., Highlighting Treatment Access Gap in Europe

TAIPEI, Taiwan--(BUSINESS WIRE)--PharmaEssentia’s blood cancer treatment, ropeginterferon alfa-2b (Ropeg), has secured approvals for essential thrombocythemia (ET) in Taiwan, Japan, the United States, and China, widening treatment options for patients with the chronic disease. In Europe, however, the ET indication remains unapproved, underscoring the gap between clinical advances and patient access across global markets. Developed and manufactured by the Taiwan-based biopharmaceutical company P...
-

Expro Announces Third Quarter 2026 Results

HOUSTON--(BUSINESS WIRE)--Expro Ltd (NYSE: XPRO) (the “Company” or “Expro”) today reported financial and operational results for the three months ended September 30, 2026. Third Quarter 2026 Highlights Revenue was $440 million Net loss of $5 million and net loss margin of 1.2% Adjusted EBITDA(1) of $91 million with an Adjusted EBITDA margin(1) of 20.7% Cash flow from operations of $65 million, or 15% of revenue Adjusted free cash flow(2) of $52 million The Company increases its 2026 annual Adju...
-

USA Compression Partners Reports Third-Quarter 2026 Results

DALLAS--(BUSINESS WIRE)--USA Compression Partners, LP (TXSE: USAC) (“USA Compression” or the “Partnership”) announced today its financial and operating results for third-quarter 2026. Financial Highlights Total revenues of $357.2 million for third-quarter 2026, compared to $250.3 million for third-quarter 2025. Net income was $47.3 million for third-quarter 2026, compared to $34.5 million for third-quarter 2025. Net cash provided by operating activities was $117.7 million for third-quarter 2026...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Global Equity Income UCITS ETF 02.11.2026 FGBL.LN IE00BYTH6121  464,196.00 USD  46,718,815.85  100.645  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust US Equity Opportunities UCITS ETF 02.11.2026 FPX. IE00BYTH6238  225,002.00 USD  13,996,995.62   62.208  ...
-

First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s)

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust Global Equity Income UCITS ETF 02.11.2026 GINC LN IE00BD842Y21  913,058.00 USD  59,653,808.24   65.334  ...
-

Kontoor Brands Completes the Sale of the Lee® Business to Authentic Brands Group

GREENSBORO, N.C.--(BUSINESS WIRE)--Kontoor Brands, Inc. (NYSE: KTB) today announced it has completed the sale of the Lee® business to Authentic Brands Group. "I want to thank the Kontoor team for the tremendous effort that drove the successful completion of this transaction," said Scott Baxter, Chief Executive Officer and Chairman of the Board of Kontoor Brands. “We now have a more focused, growth-oriented portfolio positioned to deliver stronger returns for our shareholders.” "We are grateful...